Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013453 |
---|---|
Receipt number | R000015709 |
Scientific Title | A multi-center, randomized, double-blind, placebo-controlled trial to determine the efficacy of rituximab against a relapse of neuromyelitis optica spectrum disorders with anti-aquaporin 4 antibody |
Date of disclosure of the study information | 2014/03/18 |
Last modified on | 2020/08/20 23:57:46 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/03/18 16:00:14 | ||
2 | Update | 2014/08/17 21:41:48 | Recruitment status |
|
3 | Update | 2014/10/20 15:43:35 | Key exclusion criteria Key exclusion criteria |
|
4 | Update | 2015/04/17 14:35:06 | Anticipated trial start date |
|
5 | Update | 2015/04/17 14:49:31 | Organization Organization Research ethics review Institutions |
|
6 | Update | 2015/04/17 14:58:44 | Homepage URL |
|
7 | Update | 2016/03/18 10:02:10 | Organization Institutions |
|
8 | Update | 2016/10/21 09:30:59 | Name of primary person or sponsor Institute Organization Organization Category of Funding Organization |
|
9 | Update | 2017/11/10 15:19:17 | Recruitment status Last follow-up date |
|
10 | Update | 2018/12/19 12:20:13 | Email |
|
11 | Update | 2019/03/28 13:30:06 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Last name of contact person Last name of contact person Organization Zip code Organization Organization Institute Organization Organization Address Address Tel |
|
12 | Update | 2019/03/28 13:35:54 | Date of IRB |
|
13 | Update | 2019/03/28 13:37:30 | Number of participants that the trial has enrolled |
|
14 | Update | 2019/09/13 10:33:44 | Recruitment status Date of closure to data entry Date trial data considered complete |
|
15 | Update | 2020/08/20 23:57:46 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |